- Telehealth Visits
- Insurance plan information
Tammy T. Chang, MD, PhD
Gastrointestinal SurgeryTammy T. Chang, MD, PhD
Gastrointestinal SurgeryGeneral Surgery Parnassus
- Telehealth Visits
- Insurance plan information
On this page
About me
Dr. Tammy T. Chang is a surgeon who specializes in gastrointestinal conditions as well as urgent conditions requiring prompt treatment.
Chang directs a research laboratory that focuses on liver tissue engineering and regenerative surgical therapies, which stimulate the formation of new tissue.
Chang earned her combined medical and doctoral degrees at Harvard Medical School. She completed her general surgery residency at UCSF, followed by her fellowship in minimally invasive gastrointestinal surgery.
Education & training
Board certification
- General Surgery, American Board of Surgery
Fellowship
- Minimally Invasive Surgery, UCSF Graduate Medical Education
Residency
- General Surgery, UCSF Graduate Medical Education
Internship
- General Surgery, UCSF Graduate Medical Education
Degree
- MD, Harvard Medical School
My expertise
Specialties
Conditions
Locations
My research
Publications
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.